Matthew Hankins
Overview
Explore the profile of Matthew Hankins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1566
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Plas A, Antunes M, Pouly S, de La Bourdonnaye G, Hankins M, Heremans A
Toxicol Rep
. 2023 Mar;
10:367-375.
PMID: 36926662
Smoking increases lipid levels, including triglycerides, leading to increased cardiovascular disease risk. We performed a meta-analysis to quantify the effects of smoking and smoking cessation on triglyceride levels. The PubMed...
2.
Kauss A, Antunes M, de La Bourdonnaye G, Pouly S, Hankins M, Heremans A, et al.
Toxicol Rep
. 2022 Dec;
9:1150-1171.
PMID: 36518393
Background: Apolipoproteins are major components of lipoproteins such as high-density lipoprotein (HDL) and very-low-density lipoprotein and are considered nontraditional markers in the risk assessment for cardiovascular disease. The goal of...
3.
van der Plas A, Antunes M, Romero-Kauss A, Hankins M, Heremans A
Front Public Health
. 2022 Jul;
10:909459.
PMID: 35836991
To substantiate the beneficial effects of switching from cigarette smoking to heated tobacco products (HTP), this study conducted a time-trend analysis using data from the Japanese Medical Data Center (JMDC)...
4.
Kauss A, Antunes M, Zanetti F, Hankins M, Hoeng J, Heremans A, et al.
Toxicol Rep
. 2022 Mar;
9:316-322.
PMID: 35284240
Background: Halitosis is the general term used to describe any disagreeable odor in exhaled air, regardless of whether the odorous substances originate from oral or non-oral sources. Previous research has...
5.
Chan A, Horne R, Hankins M, Chisari C
Br J Clin Pharmacol
. 2019 Dec;
86(7):1281-1288.
PMID: 31823381
Aims: This study aimed to establish the psychometric properties of a questionnaire measure of patients' adherence to medications to elicit patients' report of medication use in a variety of clinical...
6.
Miles C, Arden-Close E, Thomas M, Bruton A, Yardley L, Hankins M, et al.
NPJ Prim Care Respir Med
. 2017 Oct;
27(1):57.
PMID: 28993623
Self-management is an established, effective approach to controlling asthma, recommended in guidelines. However, promotion, uptake and use among patients and health-care professionals remain low. Many barriers and facilitators to effective...
7.
Hankins M, Tsai K, Kim J, Hammar N
Diabetes Res Clin Pract
. 2017 Jan;
125:29-38.
PMID: 28131071
Objectives: Dapagliflozin is an inhibitor of the human sodium-glucose co-transporter 2 (SGLT2) that has been shown to improve glycaemic control in patients with type 2 diabetes mellitus (T2DM). This study...
8.
Walburn J, Weinman J, Norton S, Hankins M, Dawe K, Banjoko B, et al.
Psychosom Med
. 2016 Dec;
79(5):585-592.
PMID: 27941577
Objective: The aim of the study was to investigate the impact of stress, illness perceptions, and behaviors on healing of venous leg ulcers. Methods: A prospective observational study of 63...
9.
Wagland R, Richardson A, Ewings S, Armes J, Lennan E, Hankins M, et al.
Support Care Cancer
. 2016 Jul;
24(12):4901-4911.
PMID: 27465050
Purpose: The purpose of this study was to identify the treatment-associated problems that most impact on patients undergoing cancer chemotherapy, how problems relate to experiences of supportive care and variations...
10.
Kolaczynski W, Hankins M, Ong S, Richter H, Clemens A, Toussi M
Diabetes Ther
. 2016 Jun;
7(3):483-96.
PMID: 27262995
Introduction: Preliminary data suggest that dipeptidyl peptidase-4 (DPP-4) inhibitors may reduce microvascular events, but there is a little evidence to support this from adequate real-world studies. This study aimed to...